Enzo Historical Balance Sheet

ENZ Stock

USD 1.08 0.05 4.85%

Trend analysis of Enzo Biochem balance sheet accounts such as Other Current Liabilities of 23.6 M or Total Current Liabilities of 15.1 M provides information on Enzo Biochem's total assets, liabilities, and equity, which is the actual value of Enzo Biochem to its prevalent stockholders. By breaking down trends over time using Enzo Biochem balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Enzo Biochem latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Enzo Biochem is a good buy for the upcoming year.

Enzo Biochem Inventory

5.61 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

About Enzo Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Enzo Biochem at a specified time, usually calculated after every quarter, six months, or one year. Enzo Biochem Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Enzo Biochem and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Enzo currently owns. An asset can also be divided into two categories, current and non-current.

Enzo Biochem Balance Sheet Chart

At this time, Enzo Biochem's Good Will is fairly stable compared to the past year. Non Current Liabilities Other is likely to rise to about 15.4 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 3.3 M in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Short Term Investments

Add Fundamental

Total Assets

Total assets refers to the total amount of Enzo Biochem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Enzo Biochem books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Short Term Investments

Short Term Investments is an item under the current assets section of Enzo Biochem balance sheet. It contains any investments Enzo Biochem undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Enzo Biochem can easily liquidate in the marketplace.

Most accounts from Enzo Biochem's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Good Will is fairly stable compared to the past year. Non Current Liabilities Other is likely to rise to about 15.4 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 3.3 M in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	20.6M	7.0M	3.5M	3.3M
Total Assets	95.9M	121.9M	85.8M	100.6M

Short Long Term Debt Total Total Assets

Enzo Biochem balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		0.05	0.25	0.32	0.83	0.49	-0.54	-0.15	0.67	0.21	-0.1	0.81	-0.18	0.47	0.02	0.14	0.26	0.3	0.23	0.42	0.9	-0.59	0.01	0.1	0.42	0.47
Short Long Term Debt Total	0.05		-0.27	-0.24	-0.44	0.41	0.55	0.66	-0.05	0.46	0.79	0.02	-0.55	-0.55	0.97	-0.14	-0.03	-0.62	0.86	0.23	-0.14	-0.45	-0.38	0.36	-0.57	-0.58
Other Current Liab	0.25	-0.27		0.51	0.19	0.11	-0.41	-0.36	0.3	-0.19	-0.25	0.3	-0.49	0.26	-0.26	0.01	0.48	0.2	0.05	0.4	0.27	0.33	-0.48	-0.07	0.35	0.36
Total Current Liabilities	0.32	-0.24	0.51		0.18	0.51	-0.11	-0.71	0.02	0.42	-0.6	0.06	0.12	0.74	-0.42	0.51	0.2	0.75	0.26	0.44	0.18	0.19	0.2	0.51	0.7	0.73
Total Stockholder Equity	0.83	-0.44	0.19	0.18		0.11	-0.77	-0.33	0.65	-0.12	-0.39	0.72	0.17	0.57	-0.43	0.1	0.16	0.46	-0.34	0.12	0.87	-0.38	0.25	-0.2	0.53	0.58
Property Plant And Equipment Net	0.49	0.41	0.11	0.51	0.11		0.36	-0.35	-0.17	0.87	-0.14	-0.01	-0.28	0.45	0.27	0.67	0.54	0.36	0.63	0.82	0.1	-0.3	-0.08	0.63	0.43	0.44
Net Debt	-0.54	0.55	-0.41	-0.11	-0.77	0.36		0.14	-0.86	0.61	0.25	-0.78	-0.05	-0.34	0.49	0.35	0.0	-0.25	0.44	0.16	-0.8	0.1	-0.02	0.49	-0.35	-0.37
Retained Earnings	-0.15	0.66	-0.36	-0.71	-0.33	-0.35	0.14		0.24	-0.24	0.95	0.22	-0.38	-0.86	0.77	-0.63	-0.44	-0.9	0.33	-0.38	-0.01	-0.33	-0.34	-0.27	-0.88	-0.9
Cash	0.67	-0.05	0.3	0.02	0.65	-0.17	-0.86	0.24		-0.43	0.19	0.95	-0.25	0.11	0.0	-0.48	-0.05	-0.04	0.01	-0.05	0.88	-0.41	-0.18	-0.36	0.1	0.11
Non Current Assets Total	0.21	0.46	-0.19	0.42	-0.12	0.87	0.61	-0.24	-0.43		-0.08	-0.3	0.0	0.28	0.28	0.72	0.16	0.3	0.6	0.55	-0.19	-0.18	0.22	0.74	0.18	0.22
Non Currrent Assets Other	-0.1	0.79	-0.25	-0.6	-0.39	-0.14	0.25	0.95	0.19	-0.08		0.19	-0.55	-0.8	0.88	-0.51	-0.27	-0.87	0.52	-0.15	-0.04	-0.38	-0.5	-0.19	-0.8	-0.83
Cash And Short Term Investments	0.81	0.02	0.3	0.06	0.72	-0.01	-0.78	0.22	0.95	-0.3	0.19		-0.28	0.16	0.07	-0.37	0.0	-0.02	0.11	0.03	0.96	-0.56	-0.17	-0.25	0.15	0.16
Net Receivables	-0.18	-0.55	-0.49	0.12	0.17	-0.28	-0.05	-0.38	-0.25	0.0	-0.55	-0.28		0.35	-0.63	0.16	-0.54	0.5	-0.54	-0.55	-0.12	0.07	0.92	0.15	0.25	0.28
Common Stock Shares Outstanding	0.47	-0.55	0.26	0.74	0.57	0.45	-0.34	-0.86	0.11	0.28	-0.8	0.16	0.35		-0.66	0.62	0.34	0.97	-0.17	0.39	0.39	-0.02	0.38	0.21	0.98	0.99
Non Current Liabilities Total	0.02	0.97	-0.26	-0.42	-0.43	0.27	0.49	0.77	0.0	0.28	0.88	0.07	-0.63	-0.66		-0.26	0.01	-0.76	0.76	0.18	-0.11	-0.45	-0.51	0.17	-0.65	-0.67
Inventory	0.14	-0.14	0.01	0.51	0.1	0.67	0.35	-0.63	-0.48	0.72	-0.51	-0.37	0.16	0.62	-0.26		0.38	0.66	0.1	0.62	-0.15	0.19	0.26	0.28	0.56	0.58
Other Current Assets	0.26	-0.03	0.48	0.2	0.16	0.54	0.0	-0.44	-0.05	0.16	-0.27	0.0	-0.54	0.34	0.01	0.38		0.2	0.1	0.84	0.08	0.11	-0.56	-0.02	0.47	0.44
Other Stockholder Equity	0.3	-0.62	0.2	0.75	0.46	0.36	-0.25	-0.9	-0.04	0.3	-0.87	-0.02	0.5	0.97	-0.76	0.66	0.2		-0.26	0.27	0.22	0.14	0.53	0.25	0.92	0.94
Total Liab	0.23	0.86	0.05	0.26	-0.34	0.63	0.44	0.33	0.01	0.6	0.52	0.11	-0.54	-0.17	0.76	0.1	0.1	-0.26		0.47	0.01	-0.35	-0.36	0.53	-0.2	-0.2
Property Plant And Equipment Gross	0.42	0.23	0.4	0.44	0.12	0.82	0.16	-0.38	-0.05	0.55	-0.15	0.03	-0.55	0.39	0.18	0.62	0.84	0.27	0.47		0.12	0.02	-0.46	0.21	0.43	0.44
Total Current Assets	0.9	-0.14	0.27	0.18	0.87	0.1	-0.8	-0.01	0.88	-0.19	-0.04	0.96	-0.12	0.39	-0.11	-0.15	0.08	0.22	0.01	0.12		-0.54	-0.01	-0.21	0.36	0.39
Intangible Assets	-0.59	-0.45	0.33	0.19	-0.38	-0.3	0.1	-0.33	-0.41	-0.18	-0.38	-0.56	0.07	-0.02	-0.45	0.19	0.11	0.14	-0.35	0.02	-0.54		-0.09	-0.18	0.02	0.01
Accounts Payable	0.01	-0.38	-0.48	0.2	0.25	-0.08	-0.02	-0.34	-0.18	0.22	-0.5	-0.17	0.92	0.38	-0.51	0.26	-0.56	0.53	-0.36	-0.46	-0.01	-0.09		0.33	0.25	0.29
Short Term Debt	0.1	0.36	-0.07	0.51	-0.2	0.63	0.49	-0.27	-0.36	0.74	-0.19	-0.25	0.15	0.21	0.17	0.28	-0.02	0.25	0.53	0.21	-0.21	-0.18	0.33		0.16	0.18
Common Stock Total Equity	0.42	-0.57	0.35	0.7	0.53	0.43	-0.35	-0.88	0.1	0.18	-0.8	0.15	0.25	0.98	-0.65	0.56	0.47	0.92	-0.2	0.43	0.36	0.02	0.25	0.16		0.99
Common Stock	0.47	-0.58	0.36	0.73	0.58	0.44	-0.37	-0.9	0.11	0.22	-0.83	0.16	0.28	0.99	-0.67	0.58	0.44	0.94	-0.2	0.44	0.39	0.01	0.29	0.18	0.99

Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.5M	113.7M	95.9M	121.9M	85.8M	100.6M
Short Long Term Debt Total	32.8M	22.7M	20.6M	7.0M	3.5M	3.3M
Other Current Liab	10.3M	8.1M	8.2M	34.5M	22.5M	23.6M
Total Current Liabilities	32.8M	26.1M	24.6M	40.0M	24.8M	15.1M
Total Stockholder Equity	58.4M	68.6M	54.5M	78.5M	56.1M	74.8M
Property Plant And Equipment Net	34.4M	33.6M	32.4M	16.7M	15.2M	12.5M
Net Debt	(15.1M)	9.2M	(1.0M)	(75.4M)	(48.9M)	(46.4M)
Retained Earnings	(278.3M)	(270.4M)	(288.6M)	(268.4M)	(294.4M)	(279.7M)
Cash	47.9M	13.5M	21.6M	82.4M	52.4M	42.5M
Non Current Assets Total	43.8M	43.1M	41.5M	23.4M	15.7M	14.9M
Non Currrent Assets Other	1.4M	1.8M	1.6M	1.7M	530K	503.5K
Cash And Short Term Investments	47.9M	43.5M	21.6M	82.4M	52.4M	46.6M
Net Receivables	9.1M	10.2M	4.8M	4.8M	4.0M	3.8M
Common Stock Shares Outstanding	47.7M	48.3M	48.6M	49.2M	50.9M	37.4M
Liabilities And Stockholders Equity	112.5M	113.7M	95.9M	121.9M	85.8M	100.6M
Non Current Liabilities Total	21.4M	19.0M	16.8M	3.4M	4.9M	7.8M
Inventory	7.8M	12.7M	15.4M	7.9M	6.8M	5.6M
Other Current Assets	4.0M	4.2M	6.9M	3.3M	6.8M	7.2M
Other Stockholder Equity	334.5M	337.1M	339.5M	344.4M	348.1M	220.0M
Total Liab	54.2M	45.1M	41.4M	43.4M	29.7M	18.8M
Property Plant And Equipment Gross	34.4M	33.6M	63.9M	34.0M	32.0M	33.6M
Total Current Assets	68.8M	70.6M	54.4M	98.5M	70.0M	68.6M
Accumulated Other Comprehensive Income	1.7M	1.4M	3.2M	1.9M	1.9M	2.0M
Intangible Assets	1.0M	538K	244K	7.5M	6.7M	6.7M
Accounts Payable	8.5M	8.1M	3.7M	3.6M	1.4M	1.3M
Short Term Debt	11.5M	7.2M	1.1M	2.0M	917K	871.2K
Common Stock Total Equity	476K	479K	485K	487K	560.1K	422.6K
Common Stock	479K	485K	487K	499K	521K	433.3K
Other Assets	1.4M	1.8M	1.6M	6.7M	6.0M	6.3M
Property Plant Equipment	14.5M	33.6M	17.3M	16.7M	19.2M	10.2M
Current Deferred Revenue	(391K)	2.5M	2.7M	11.7M	5.9M	3.7M
Long Term Debt	4.5M	4.4M	4.1M	269K	189K	179.6K
Net Tangible Assets	50.4M	60.9M	47.0M	78.5M	90.2M	58.6M
Retained Earnings Total Equity	(252.2M)	(249.7M)	(278.3M)	(288.6M)	(259.8M)	(272.8M)
Capital Surpluse	334.5M	337.1M	339.5M	344.4M	396.1M	359.7M
Non Current Liabilities Other	424K	16.9M	5K	12.8M	14.7M	15.4M
Short Long Term Debt	7.1M	152K	229K	2.6M	76K	72.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enzo Historical Balance Sheet

Enzo Biochem Inventory

5.61 Million

About Enzo Balance Sheet Analysis

Enzo Biochem Balance Sheet Chart

Total Assets

Short Term Investments

Enzo Biochem balance sheet Correlations

Enzo Biochem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enzo Biochem balance sheet Accounts

Also Currently Popular

Additional Tools for Enzo Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Total Equity
Common Stock Total Equity	+ 0.98	Common Stock Shares Outstanding
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Other Stockholder Equity	+ 0.97	Common Stock Shares Outstanding
Total Current Assets	+ 0.96	Cash And Short Term Investments

Common Stock	- 0.9	Retained Earnings
Other Stockholder Equity	- 0.9	Retained Earnings
Common Stock Total Equity	- 0.88	Retained Earnings
Other Stockholder Equity	- 0.87	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.86	Retained Earnings
Cash	- 0.86	Net Debt